First Trust Nasdaq Pharmaceuticals ETF
FTXH
FTXH
19 hedge funds and large institutions have $10.2M invested in First Trust Nasdaq Pharmaceuticals ETF in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
86% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 7
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.06M | |
| 2 | +$696K | |
| 3 | +$318K | |
| 4 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
+$13.6K |
| 5 |
OWA
Outlook Wealth Advisors
Shenandoah,
Texas
|
+$8.11K |
Top Sellers
| 1 | -$739K | |
| 2 | -$686K | |
| 3 | -$602K | |
| 4 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$568K |
| 5 |
WFA
WMG Financial Advisors
Knoxville,
Tennessee
|
-$563K |